| Product NDC: | 0832-0233 |
| Proprietary Name: | Morphine Sulfate |
| Non Proprietary Name: | Morphine Sulfate |
| Active Ingredient(s): | 100 mg/1 & nbsp; Morphine Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0832-0233 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202104 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130630 |
| Package NDC: | 0832-0233-50 |
| Package Description: | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-50) |
| NDC Code | 0832-0233-50 |
| Proprietary Name | Morphine Sulfate |
| Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-0233-50) |
| Product NDC | 0832-0233 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Morphine Sulfate |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20130630 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | MORPHINE SULFATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |